Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
Investor Relations
Overview
Stock Quote
Presentations
Frequently Asked Questions
Press Kit
SEC Filings
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
E-Alerts
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Email:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Stock Quote

Stock Symbol: NPHCD
Exchange: OTC
Last Trade: 0.145*
Change: +0.005
Volume: 62500
*Quote delayed 20 minutes.

 

 
Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.
 

 

 
Recent News
 
May 26, 2015
Nutra Pharma Announces Orphan Drug Applications for RPI-78M


May 14, 2015
Nutra Pharma Announces Nyloxin Distribution Plans for Canada


April 30, 2015
Nutra Pharma Announces Nyloxin Acceptance by Chinese Medical Authority - CPAM


 
 
Announcements
Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
 
 
Facebook   Twitter
 
NPC
Privacy Policy Code of Ethics